FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gurkamal Chatta

Research Profile

Anatomy

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Living Beings

Mouse

Physiology

Antigen Presentation

Co-author Network

Publications

TOP 3
Eva Wieckowski; Gurkamal S Chatta; Robbie M Mailliard; William Gooding; Karolina Palucka; Jacques Banchereau; Pawel Kalinski
Type-1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8(+) T cells against prostate cancer cells and defined prostate cancer-specific epitopes.
Timothy L Gillison; Gurkamal S Chatta
Cancer chemotherapy in the elderly patient.
William D Figg; Maha Hussain; James L Gulley; Philip M Arlen; Jeanny B Aragon-Ching; Daniel P Petrylak; Celestia S Higano; Seth M Steinberg; Gurkamal S Chatta; Howard L Parnes; John J Wright; Oliver Sartor; William L Dahut
A double-blind randomized crossover study of oral thalidomide versus placebo for androgen dependent prostate cancer treated with intermittent androgen ablation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gurkamal Chatta (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Eva Wieckowski; Gurkamal S Chatta; Robbie M Mailliard; William Gooding; Karolina Palucka; Jacques Banchereau; Pawel Kalinski
Type-1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8(+) T cells against prostate cancer cells and defined prostate cancer-specific epitopes.
The Prostate 2011;71(2):125-33.
2010: Timothy L Gillison; Gurkamal S Chatta
Cancer chemotherapy in the elderly patient.
Oncology (Williston Park, N.Y.) 2010;24(1):76-85.
2009: William D Figg; Maha Hussain; James L Gulley; Philip M Arlen; Jeanny B Aragon-Ching; Daniel P Petrylak; Celestia S Higano; Seth M Steinberg; Gurkamal S Chatta; Howard L Parnes; John J Wright; Oliver Sartor; William L Dahut
A double-blind randomized crossover study of oral thalidomide versus placebo for androgen dependent prostate cancer treated with intermittent androgen ablation.
The Journal of urology 2009;181(3):1104-13; discussion 1113.
2008: James L Gulley; Jeanny B Aragon-Ching; Seth M Steinberg; Maha Hussain; Oliver Sartor; Celestia S Higano; Daniel P Petrylak; Gurkamal S Chatta; Philip M Arlen; William D Figg; William L Dahut
Kinetics of serum androgen normalization and factors associated with testosterone reserve after limited androgen deprivation therapy for nonmetastatic prostate cancer.
The Journal of urology 2008;180(4):1432-7; discussion 1437.
2008: Sakkaraiappan Ramalingam; Merrill J Egorin; Ramesh K Ramanathan; Scot C Remick; Rachel Sikorski; Theodore F Lagattuta; Gurkamal S Chatta; David M Friedland; Ronald G Stoller; Douglas M Potter; S Percy Ivy; Chandra P Belani
A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3456-61.
2008: Tomasz M Beer; Christopher W Ryan; Peter M Venner; Daniel P Petrylak; Gurkamal S Chatta; J Dean Ruether; Kim N Chi; James Young; W David Henner
Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel.
Cancer 2008;112(2):326-30.
2007: Michael R Shurin; Galina V Shurin; Gurkamal S Chatta
Aging and the dendritic cell system: implications for cancer.
Critical reviews in oncology/hematology 2007;64(2):90-105.
2007: Galina V Shurin; Zoya R Yurkovetsky; Gurkamal S Chatta; Irina L Tourkova; Michael R Shurin; Anna Lokshin
Dynamic alteration of soluble serum biomarkers in healthy aging.
Cytokine 2007;39(2):123-9.
2007: Maha Hussain; Gary R MacVicar; Daniel P Petrylak; Rodney L Dunn; Ulka Nitin Vaishampayan; Primo Lara; Gurkamal S Chatta; David M Nanus; L Michael Glode; Donald L Trump; Helen Chen; David C Smith
Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(16):2218-24.
2007: Adam S Kibel; Eli Rosenbaum; Michael W Kattan; Joel Picus; Robert Dreicer; Eric A Klein; Gurkamal S Chatta; Joel B Nelson; Robert S DiPaola; Bruce J Roth; Michael S Cookson; George Wilding; David F Jarrard; Tomasz M Beer; Christopher W Ryan; Daniel P Petrylak; Mitchell C Benson; Alan W Partin; Elizabeth Garrett-Mayer; Mario A Eisenberger
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
The Journal of urology 2007;177(5):1777-81.
2007: Ramesh K Ramanathan; Merrill J Egorin; Julie L Eiseman; Sakkaraiappan Ramalingam; David M Friedland; Sanjiv S Agarwala; S Percy Ivy; Douglas M Potter; Gurkamal S Chatta; Eleanor G Zuhowski; Ronald G Stoller; Cynthia Naret; Jianxia Guo; Chandra P Belani
Phase I and pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with refractory advanced cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1769-74.
2007: Tomasz M Beer; Christopher W Ryan; Peter M Venner; Daniel P Petrylak; Gurkamal S Chatta; J Dean Ruether; Charles H Redfern; Louis Fehrenbacher; Mansoor N Saleh; David M Waterhouse; Michael A Carducci; Daniel Vicario; Robert Dreicer; Celestia S Higano; Frederick R Ahmann; Kim N Chi; W David Henner; Alan Arroyo; Fong W Clow
Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(6):669-74.
2007: Maryam Aalamian-Matheis; Gurkamal S Chatta; Michael R Shurin; Edith Huland; Hartwig Huland; Galina V Shurin
Inhibition of dendritic cell generation and function by serum from prostate cancer patients: correlation with serum-free PSA.
Advances in experimental medicine and biology 2007;601():173-82.
2006: Tomasz M Beer; Peter M Venner; Christopher W Ryan; Daniel P Petrylak; Gurkamal S Chatta; J Dean Ruether; Kim N Chi; John G Curd; Thomas G Deloughery
High dose calcitriol may reduce thrombosis in cancer patients.
British journal of haematology 2006;135(3):392-4.
2006: Michael R Shurin; Galina V Shurin; Anna Lokshin; Zoya R Yurkovetsky; Dmitry W Gutkin; Gurkamal S Chatta; Hua Zhong; Baohui Han; Robert L Ferris
Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies?
Cancer metastasis reviews 2006;25(3):333-56.
2005: Irina L Tourkova; Galina V Shurin; Gurkamal S Chatta; Lori Perez; James Finke; Theresa L Whiteside; Soldano Ferrone; Michael R Shurin
Restoration by IL-15 of MHC class I antigen-processing machinery in human dendritic cells inhibited by tumor-derived gangliosides.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(5):3045-52.
2005: Galina V Shurin; Robert L Ferris; Robert Ferris; Irina L Tourkova; Lori Perez; Anna Lokshin; Levent Balkir; Bobby Collins; Gurkamal S Chatta; Michael R Shurin
Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(9):5490-8.
2005: James L Gulley; William D Figg; Seth M Steinberg; Jane Carter; Oliver Sartor; Celestia S Higano; Daniel P Petrylak; Gurkamal S Chatta; Maha Hussain; William L Dahut
A prospective analysis of the time to normalization of serum androgens following 6 months of androgen deprivation therapy in patients on a randomized phase III clinical trial using limited hormonal therapy.
The Journal of urology 2005;173(5):1567-71.
2005: Ramesh K Ramanathan; Sakkaraiappan Ramalingam; Merrill J Egorin; Chandra P Belani; Douglas M Potter; Marwan G Fakih; Laura L Jung; Sandra Strychor; Samuel A Jacobs; David M Friedland; Dong M Shin; Gurkamal S Chatta; Susan Tutchko; William C Zamboni
Phase I study of weekly (day 1 and 8) docetaxel in combination with capecitabine in patients with advanced solid malignancies.
Cancer chemotherapy and pharmacology 2005;55(4):354-60.
2005: Galina V Shurin; Irina L Tourkova; Gurkamal S Chatta; Gudula Schmidt; Sheng Wei; Julie Y Djeu; Michael R Shurin
Small rho GTPases regulate antigen presentation in dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(6):3394-400.
2004: E Y Song; Michael R Shurin; Irina L Tourkova; Gurkamal S Chatta; Galina V Shurin
Human renal cell carcinoma inhibits dendritic cell maturation and functions.
Der Urologe. Ausg. A 2004;43 Suppl 3():S128-30.
2004: Levent Balkir; Irina L Tourkova; Valeria P Makarenkova; Galina V Shurin; Paul D Robbins; Xiao-Ming Yin; Gurkamal S Chatta; Michael R Shurin
Comparative analysis of dendritic cells transduced with different anti-apoptotic molecules: sensitivity to tumor-induced apoptosis.
The journal of gene medicine 2004;6(5):537-44.
2004: Irina L Tourkova; Kazuo Yamabe; Barbara Foster; Gurkamal S Chatta; Lori Perez; Galina V Shurin; Michael R Shurin
Murine prostate cancer inhibits both in vivo and in vitro generation of dendritic cells from bone marrow precursors.
The Prostate 2004;59(2):203-13.
2004: Galina V Shurin; Gurkamal S Chatta; Irina L Tourkova; tatiana Zorina; Clemens Esche; Michael R Shurin
Regulation of dendritic cell expansion in aged athymic nude mice by FLT3 ligand.
Experimental gerontology 2004;39(3):339-48.
2003: Irina L Tourkova; Kazuo Yamabe; Gurkamal S Chatta; Galina V Shurin; Michael R Shurin
NK cells mediate Flt3 ligand-induced protection of dendritic cell precursors in vivo from the inhibition by prostate carcinoma in the murine bone marrow metastasis model.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2003;26(6):468-72.
2003: Maryam Aalamian; Irina L Tourkova; Gurkamal S Chatta; Hans Lilja; Edith Huland; Hartwig Huland; Galina V Shurin; Michael R Shurin
Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen.
The Journal of urology 2003;170(5):2026-30.
2001: Omer Kucuk; E Fisher; Carol M Moinpour; D Coleman; Maha Hussain; A O Sartor; Gurkamal S Chatta; Bruce A Lowe; Mario A Eisenberger; E David Crawford
Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235).
Urology 2001;58(1):53-8.